
Thursday, May 01, 2025 11:18:32 AM
https://listingcenter.nasdaq.com/assets/initialguide.pdf
The bashturds, as hard as they run on their hamster wheel of delusion and misdirection, are irrelevant. The posts are laughable. The only thing a newbie investor, or a current investor w/ the onset of 'cold feet', needs to repeat as a mantra, over and over again, is the following quote. It's coming, and in a BIG way. YMIGH I couldn't tell you in any definitive way what the latest filings are intended to be. It doesn't matter, to me, at least. That's the CEO's job and I think he's doing a fine job. Godspeed to KBLB.
“The successful execution of simultaneous production batches in our new facilities demonstrates the scalability of our technology from batch processing to continuous flow manufacturing,” said Kim Thompson, Founder and CEO of Kraig Labs. “With this cycle nearing completion and the next generation of BAM-1 hybrids already prepared, we are in a strong position to rapidly accelerate the growth and commercialization of our spider silk.”
We are the * NEXT * BIG * THING *
Later, WBeacham

To find out who your rulers are, simply find out who you can not criticize in public
Recent KBLB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2025 09:10:15 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2025 08:30:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2025 08:30:48 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/30/2025 04:15:09 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/29/2025 11:37:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/17/2025 09:00:55 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/17/2025 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2025 08:44:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2025 09:09:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/28/2025 08:46:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2025 08:30:35 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/14/2025 05:11:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/13/2025 10:21:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2025 10:14:03 PM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 12/19/2024 09:30:04 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/19/2024 09:05:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 09:30:40 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 09:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:52 PM
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM